Tibet Duo Rui Pharmaceutical Co., Ltd. (SHE:301075)

China · Delayed Price · Currency is CNY

58.94

-0.16 (-0.27%)

At close: Jul 3, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Preparations	55.36M	186.79M	-	297.92M	465.37M
Preparations Growth	-70.36%	-	-	-35.98%	-
Intermediate	38.96M	38.00M	-	103.13M	64.24M
Intermediate Growth	2.52%	-	-	60.53%	-
Active Pharmaceutical Ingredient (api)	49.74M	10.32M	-	-	-
Active Pharmaceutical Ingredient (api) Growth	381.74%	-	-	-	-
Others	10.11M	5.51M	-	-	-
Others Growth	83.55%	-	-	-	-
Total	154.18M	240.63M	-	401.05M	529.62M
Total Growth	-35.93%	-	-	-24.28%	8.05%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
China	154.18M	240.63M	334.30M	401.05M	529.62M
China Growth	-35.93%	-28.02%	-16.64%	-24.28%	8.05%
Total	154.18M	240.63M	334.30M	401.05M	529.62M
Total Growth	-35.93%	-28.02%	-16.64%	-24.28%	8.05%